BDBM50099767 4-(1-{2-[3-Carboxy-1-(carboxymethyl-carbamoyl)-propylcarbamoyl]-pyrrolidine-1-carbonyl}-4-guanidino-butylcarbamoyl)-4-[(9,10-dioxo-9,10-dihydro-phenanthrene-2-carbonyl)-amino]-butyric acid::CHEMBL50793
SMILES NC(=N)NCCCC(NC(=O)C(CCC(O)=O)NC(=O)c1ccc2-c3ccccc3C(=O)C(=O)c2c1)C(=O)N1CCCC1C(=O)NC(CCC(O)=O)C(=O)NCC(O)=O
InChI Key InChIKey=KLNGECIRRKCNNN-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 50099767
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 700nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair